ApprovalTrail

Approval · Notice of Compliance 7854 · 2006

RAMACE: Notice of Compliance 7854

Issued March 29, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
7854
Date
March 29, 2006
Company
Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Angiotensin converting enzyme inhibitor

Products in this notice

BrandDINStatus today
RAMACE02051788—
RAMACE02051796—
RAMACE02051818—
RAMACE02242874—
RAMACE02248884Cancelled Pre Market
RAMACE02248885Cancelled Pre Market
RAMACE02248886Cancelled Pre Market
RAMACE02248887Cancelled Pre Market

Medicinal ingredients